StockData
Sensient Technologies Corp logo

Sensient Technologies Corp (SXT) stock analysis

SXTNYSEIndustrial Organic ChemicalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 14/3024% above fair value
$118.81−2.28 (-1.88%)

Close on Nov 11, 2026Market cap $5.06BP/E 29.9Yield 1.38%

StockData Score

Prices as of Nov 11, 2026How the score works

Value0Growth4Performance4Health3Dividend3

Mixed14 of 30 checks passed

Sensient Technologies passes 14 of the 30 checks behind our score; 1 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
0/6
Growth
4/6
Past performance
4/6
Financial health
3/6
Dividend
3/6

What stands out

  • Earnings grew over 5 years

    Net income grew 4.2% a year on average over the last five fiscal years.

  • Earnings growth accelerating

    Net income grew 21.7% over the last twelve months, against a 5-year average of 4.2% a year.

  • Interest well covered

    Operating income covers interest expense 8.0 times.

  • Low bankruptcy risk

    The Altman Z-score is 5.16; above 3 is the safe zone and below 1.8 the distress zone.

What to watch

  • Margin of safety under 20%

    The price is 24.3% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $118.81 is above our fair value estimate of $95.56.

  • Return on equity under 15%

    Return on equity was 13.7% over the last twelve months and averaged 12.0% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 10.0%, below the 10% that usually covers the cost of capital.

Valuation0/6
  • P/E above its 5-year median

    Sensient Technologies's P/E of 29.9 is above its own 5-year median of 29.7.

  • P/E above the industry

    Sensient Technologies's P/E of 29.9 is above the Chemicals and Allied Products median of 25.2.

  • EV/EBITDA above its 5-year median

    Sensient Technologies's EV/EBITDA of 18.3 is above its 5-year median of 17.5.

  • P/B above the industry

    Sensient Technologies's price-to-book of 3.93 is above the Chemicals and Allied Products median of 1.51.

  • Trading above fair value

    The share price of $118.81 is above our fair value estimate of $95.56.

  • Margin of safety under 20%

    The price is 24.3% above fair value, so there is no margin of safety.

Growth4/6
  • Revenue growing under 10% a year

    Revenue grew 3.9% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew -1.8% a year over the last three fiscal years.

  • Earnings growth accelerating

    Net income grew 21.7% over the last twelve months, against a 5-year average of 4.2% a year.

  • Growing faster than the industry

    Revenue grew 9.5% over the last twelve months; the Chemicals and Allied Products median is 3.5%.

  • Guidance raised

    Sensient Technologies raised its 2026 Diluted EPS (GAAP) outlook on Apr 24, 2026.

  • Gross margin improving

    Gross margin was 35.1% over the last twelve months, against 33.6% a year earlier.

Past performance4/6
  • Return on equity under 15%

    Return on equity was 13.7% over the last twelve months and averaged 12.0% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 10.0%, below the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Sensient Technologies's return on equity of 13.7% is above the Chemicals and Allied Products median of -16.2%.

  • Earnings grew over 5 years

    Net income grew 4.2% a year on average over the last five fiscal years.

  • Net margin above its 5-year average

    Net margin was 9.7% over the last twelve months, against a 5-year average of 8.2%.

  • Net margin above the industry

    Sensient Technologies's net margin of 9.7% is above the Chemicals and Allied Products median of -13.3%.

Financial health3/6
  • High debt

    Debt is 61.4% of shareholders' equity, above the 40% we consider low.

  • Debt rising against equity

    Debt to equity rose from 57.4% five years ago to 61.4%.

  • Debt not well covered by cash flow

    Operating cash flow over the last twelve months equals 15.2% of total debt; we look for at least 20%.

  • Interest well covered

    Operating income covers interest expense 8.0 times.

  • Short-term assets cover short-term debts

    Current assets are 3.97 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 5.16; above 3 is the safe zone and below 1.8 the distress zone.

Dividend3/6
  • Pays a dividend

    Sensient Technologies paid dividends worth 1.0% of the share price over the last twelve months.

  • Yield below Treasuries

    The 1.0% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Sensient Technologies yields 1.0%.

  • Dividend not cut

    The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.

  • Covered by earnings

    Dividends take 41.2% of net income.

  • Cash-flow cover

    Needs dividends paid and free cash flow.

Scores of similar companies

Our estimate per share

$95.56

The share price is 24% above this estimate.

20%+ below
Near fair value
20%+ above
$118.81Price$95.56Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E27.5×29.7×25.2×$109.2047%
EV/EBITDA14.0×17.5×10.4×$86.7341%
P/B2.4×3.2×1.5×$71.9012%
Earnings powerleft out, too far from the others9.0% cost of equity––$23.95–
Fair value$95.56100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 29.7
  • Chemicals and Allied Products median 25.2

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$61.12M
Value traded per 1% price move
$42.14M

Downside

Low risk

Typical loss in a bad month
11.4%
Volatility (annualized)
41%
Sharpe ratio, 1 year
0.57
Beta to the S&P 500 (5Y)
0.83

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

33.5%+1.6 pts over 5 years

Operating margin

12.8%+1.4 pts over 5 years

Net margin

8.3%+0.1 pts over 5 years

See a number that looks wrong?